Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 2677092)

Published in J Allergy Clin Immunol on October 01, 1989

Authors

J Bousquet1, H J Maasch, A Hejjaoui, W Skassa-Brociek, R Wahl, H Dhivert, F B Michel

Author Affiliations

1: Clinique des Maladies Respiratoires, Hopital L'Aiguelongue, Centre Hospitalier Universitaire, Montpellier, France.

Articles by these authors

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med (1988) 2.63

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res (1993) 1.98

Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med (1994) 1.88

111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun (2003) 1.78

Compilation of DNA sequences of Escherichia coli (update 1991). Nucleic Acids Res (1991) 1.73

Measurement of the internal size of bronchi using high resolution computed tomography (HRCT) Eur Respir J (1994) 1.67

Undertreatment in a nonselected population of adult patients with asthma. J Allergy Clin Immunol (1996) 1.53

Compilation of DNA sequences of Escherichia coli (update 1992). Nucleic Acids Res (1992) 1.52

Precision of skin prick and puncture tests with nine methods. J Allergy Clin Immunol (1991) 1.50

How allergenic are hypoallergenic infant formulae? Clin Exp Allergy (1992) 1.42

Comparison of cord blood immunoglobulin E concentrations and maternal allergy for the prediction of atopic diseases in infancy. J Allergy Clin Immunol (1980) 1.40

The allergen of Ficus benjamina in house dust. Clin Exp Allergy (1995) 1.39

[Application of the WHO chronic respiratory diseases programme in Sub-Saharian Africa: problems in Senegal]. Rev Mal Respir (2004) 1.39

Compilation of DNA sequences of Escherichia coli (update 1990). Nucleic Acids Res (1990) 1.36

Compilation of DNA sequences of Escherichia coli (update 1993). Nucleic Acids Res (1993) 1.34

Asthma: a disease remodeling the airways. Allergy (1992) 1.30

Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med (1996) 1.28

HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis (1993) 1.26

Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis (1992) 1.26

Asthma mortality in France. J Allergy Clin Immunol (1987) 1.25

Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. J Allergy Clin Immunol (1982) 1.24

Quantitative imaging and sigmoidoscopy to assess distribution of rectal microbicide surrogates. Clin Pharmacol Ther (2007) 1.19

Functional characteristics of bronchial epithelium obtained by brushing from asthmatic and normal subjects. Am Rev Respir Dis (1993) 1.17

Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol (1991) 1.17

Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol (1987) 1.14

Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers. Cancer Res (1989) 1.09

Skin test reactivity in infancy. J Allergy Clin Immunol (1985) 1.07

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol (1990) 1.06

Differences in IL-4 release by PBMC are related with heterogeneity of atopy. Immunology (1994) 1.04

Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma. J Allergy Clin Immunol (1990) 1.03

Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Respir Crit Care Med (1994) 1.03

Allergy in the Mediterranean area. II: Cross-allergenicity among Urticaceae pollens (Parietaria and Urtica). Clin Allergy (1986) 1.03

Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. Int Arch Allergy Appl Immunol (1990) 1.02

c-fos proto-oncogene expression in bronchial biopsies of asthmatics. Am J Respir Cell Mol Biol (1992) 1.01

Skin test reactivity to histamine from infancy to old age. J Allergy Clin Immunol (1987) 1.01

[Endoscopy and bronchiolo-alveolar lavage in allergic asthma (author's transl)]. Nouv Presse Med (1981) 1.00

Increased oxygen species generation in blood monocytes of asthmatic patients. Am Rev Respir Dis (1992) 0.99

Precision of conjunctival provocation tests in right and left eyes. J Allergy Clin Immunol (1993) 0.99

Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol (1988) 0.98

Antiallergic activity of H1-receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol (1988) 0.98

Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans. Infect Immun (1978) 0.97

Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol (1991) 0.97

Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. J Allergy Clin Immunol (1990) 0.96

Quantification and localization of HLA-DR and intercellular adhesion molecule-1 (ICAM-1) molecules on bronchial epithelial cells of asthmatics using confocal microscopy. Clin Exp Immunol (1994) 0.96

[Investigations of the quantitative aspects of the transmission of Wuchereria bancrofti in coastal areas of Liberia]. Z Tropenmed Parasitol (1973) 0.94

Specific immunotherapy in asthma. J Allergy Clin Immunol (1990) 0.93

Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med (1997) 0.93

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol (1985) 0.92

Compilation of DNA sequences of Escherichia coli K12 (ECD and ECDC; update 1995). Nucleic Acids Res (1996) 0.92

Allergy in the Mediterranean area. I. Pollen counts and pollinosis of Montpellier. Clin Allergy (1984) 0.91

Enzymes of bee venom, sac and whole body. Ann Allergy (1979) 0.90

Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol (1988) 0.90

Sensitization to different mite species in German farmers: clinical aspects. J Investig Allergol Clin Immunol (2001) 0.90

Increased expression of adhesion molecules (ICAM-1 and LFA-1) on alveolar macrophages from asthmatic patients. Allergy (1993) 0.90

Combination of passive and active immunization in honeybee venom immunotherapy. J Allergy Clin Immunol (1987) 0.90

In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. Cancer Res (1990) 0.90

Electron holography of non-stained bacterial surface layer proteins. Biochim Biophys Acta (2004) 0.90

Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS. Am J Respir Crit Care Med (1996) 0.90

Eosinophil inflammation in asthma. Am J Respir Crit Care Med (1994) 0.90

Compilation of DNA sequences of Escherichia coli K12: description of the interactive databases ECD and ECDC. Nucleic Acids Res (1998) 0.89

Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol (1996) 0.89

Safety of bronchoalveolar lavage and bronchial biopsies in patients with asthma of variable severity. Am Rev Respir Dis (1992) 0.88

Heterogeneity of atopy. I. Clinical and immunologic characteristics of patients allergic to cypress pollen. Allergy (1993) 0.88

Adsorption equilibria of thyroid hormones in the liver cell. Eur J Biochem (1977) 0.88

Bronchial elastic fibers in normal subjects and asthmatic patients. Am J Respir Crit Care Med (1996) 0.88

Purification and mass spectrometry identification of leukotriene D4 synthesized by human alveolar macrophages. Biochem Biophys Res Commun (1983) 0.88

[Immunologic research on specific and nonspecific basic protein antigens of the Streptococcus pyogenes type (group A). II. Precipitation and gel diffusion reactions. Immunogenic properties. Cutaneous allergy]. Ann Inst Pasteur (Paris) (1965) 0.88

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol (1990) 0.88

Allergy in the Mediterranean area. III: Cross reactivity among Oleaceae pollens. Clin Allergy (1985) 0.87

[The use of a laser beam in bronchology. Resection of 2 tracheo-bronchial tumours (author's transl)]. Poumon Coeur (1979) 0.87

Placebo-controlled double-blind food challenge in asthma. J Allergy Clin Immunol (1986) 0.87

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol (1988) 0.87

[Immunologic research on type-specific and nonspecific basic protein antigens of Streptococcus pyogenes (group A). 3. Electrophoresis and immunoelectrophoresis]. Ann Inst Pasteur (Paris) (1965) 0.87

5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers. Biochem Biophys Res Commun (1995) 0.86

Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy. Clin Allergy (1987) 0.86

Total serum IgE concentrations in adolescents and adults using the phadebas IgE PRIST technique. Allergy (1982) 0.86

Platelet-derived growth factor in asthma. Allergy (1995) 0.86

Interstitial pulmonary disease induced by occupational exposure to paraffin. Chest (1990) 0.86

Compilation of DNA sequences of Escherichia coli K12: description of the interactive databases ECD and ECDC (update 1996). Nucleic Acids Res (1997) 0.86

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol (1990) 0.85

Increased generation of the arachidonic metabolites LTB4 and 5-HETE by human alveolar macrophages in patients with asthma: effect in vitro of nedocromil sodium. Eur Respir J (1989) 0.85